M&A Deal Summary

Maverix Medical Acquires Cirrus Bio

On March 29, 2024, Maverix Medical acquired healthcare services company Cirrus Bio

Acquisition Highlights
  • This is Maverix Medical’s 1st transaction in the Healthcare Services sector.
  • This is Maverix Medical’s 1st transaction in the United States.
  • This is Maverix Medical’s 1st transaction in California.

M&A Deal Summary
Date 2024-03-29
Target Cirrus Bio
Sector Healthcare Services
Buyer(s) Maverix Medical
Deal Type Add-on Acquisition

Target

Cirrus Bio

Menlo Park, California, United States
Cirrus Bio develops and brings to market multi-omic solutions for the diagnosis and management of diseases where early detection plays a critical role in clinical outcomes. Cirrus Bio is based in Menlo Park, California.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Maverix Medical

Menlo Park, California, United States
Category Company
Sector Healthcare Services
DESCRIPTION

Maverix Medical provides diagnosis and treatment of lung cancer, with a mission to improve outcomes and save lives. Maverix Medical aims to bring cutting-edge technologies and innovative solutions to the forefront of lung cancer care, empowering clinicians with accurate tools and personalized treatments. Maverix Medical is based in Menlo Park, California.

DEAL STATS #
Overall 1 of 1
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
Mergr

Product

Company

Legal